CAMP4 THERAPEUTICS CORPORATION (CAMP)vsRevolution Medicines Inc (RVMD)
CAMP
CAMP4 THERAPEUTICS CORPORATION
$4.25
-2.07%
HEALTHCARE · Cap: $266.70M
RVMD
Revolution Medicines Inc
$203.77
+0.21%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
CAMP4 THERAPEUTICS CORPORATION generates 468% more annual revenue ($4.22M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. CAMP earns a higher WallStSmart Score of 25/100 (F).
CAMP
Avoid25
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
18.8% revenue growth
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Trading at 16.8x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : CAMP
The strongest argument for CAMP centers on Debt/Equity, Revenue Growth. Revenue growth of 18.8% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : CAMP
The primary concerns for CAMP are EPS Growth, Market Cap, Profit Margin.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
CAMP profiles as a growth stock while RVMD is a value play — different risk/reward profiles.
CAMP is growing revenue faster at 18.8% — sustainability is the question.
CAMP generates stronger free cash flow (-13M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
CAMP scores higher overall (25/100 vs 24/100) and 18.8% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CAMP4 THERAPEUTICS CORPORATION
HEALTHCARE · BIOTECHNOLOGY · USA
CalAmp Corp. The company is headquartered in Irvine, California.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?